Cargando…
In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
The present wellbeing worry to the whole world is the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19. This global health crisis first appeared in Wuhan, China around December 2019 and due to its extremely contagious nature it had spread to almost 1...
Autores principales: | Bhowmik, Arijit, Biswas, Souradeep, Hajra, Subhadip, Saha, Prosenjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799170/ https://www.ncbi.nlm.nih.gov/pubmed/33458435 http://dx.doi.org/10.1016/j.heliyon.2021.e05923 |
Ejemplares similares
-
Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
por: Ghosh, Rituparna, et al.
Publicado: (2022) -
COVID-19 spike-host cell receptor GRP78 binding site prediction
por: Ibrahim, Ibrahim M., et al.
Publicado: (2020) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021) -
GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective
por: Elgohary, Alaa M., et al.
Publicado: (2021) -
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico
por: Elfiky, Abdo A, et al.
Publicado: (2021)